Business
Takeda Report Highlights Company's Commitment to Cutting-Edge Science, Putting Patients First
NORTHAMPTON, MA / ACCESS Newswire / July 8, 2025 / Takeda is pleased to announce the publication of its 2025 Annual Integrated Report. The Report, available in both English and Japanese, sets out: How Takeda is investing in discovering and developing ...
About this update from Takeda Pharmaceutical Co. Ltd.
[{"type":"text","content":"NORTHAMPTON, MA / ACCESS Newswire / July 8, 2025 / Takeda is pleased to announce the publication of its 2025 Annual Integrated Report. The Report, available in both English and Japanese, sets out:","length":196,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"How Takeda is investing in discovering and developing new, life-transforming treatments","length":87,"tagName":"p"}]},{"val":[{"type":"text","content":"How the company is working with others to strengthen health care systems around the world","length":89,"tagName":"p"}]},{"val":[{"type":"text","content":"And, how it's using new data and digital technologies to revolutionize drug discovery and development.","length":106,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":282,"olType":false},{"type":"text","content":"The Report looks back on a successful FY2024 - a year of strong business performance and renewed confidence in the company's growth outlook.","length":144,"tagName":"p"},{"type":"text","content":"It also highlights Takeda's efforts to minimize its impact on the environment, support innovation and create a culture of lifelong learning for its approximately 50,000 employees worldwide.","length":193,"tagName":"p"},{"type":"text","content":""We are enhancing efficiency, growth and resilience across our organization… I am confident that we have a sustainable business strategy that will serve patients, society and shareholders well in the years ahead."","length":223,"tagName":"p"},{"type":"text","content":"- Christophe Weber, Takeda President and Chief Executive Officer","length":64,"tagName":"p"},{"type":"text","content":"Highlights of Takeda's 2025 Annual Integrated Report","length":56,"tagName":"p"},{"type":"text","content":"Groundbreaking science","length":22,"tagName":"p"},{"type":"text","content":"In FY2024, Takeda invested USD 4.9 billion in research and development (R&D). Recent R&D investments have helped the company establish an exciting late-stage pipeline, with the potential to deliver significant value to both patients and Takeda in the coming years.","length":272,"tagName":"p"},{"type":"text","content":"These late-stage programs are backed up by the company's cutting-edge research organization and a highly innovative early- to mid-stage pipeline.","length":149,"tagName":"p"},{"type":"...